Related Experiment Video
Updated: Aug 4, 2026

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein
Published on: March 9, 2015
Role still exists for cycler therapy in anuric patients with a low-transport membrane
1Division of Nephrology, Department of Medicine, University of Ottawa and Ottawa Hospital, Ottawa, Ontario, Canada.
Abstract:
It is generally believed that, to achieve adequacy targets, anuric patients with a low-transport membrane should be treated by continuous ambulatory peritoneal dialysis (CAPD) or CAPD with a night-exchange device. If adequacy targets are not reached, it is suggested that patients should be changed to hemodialysis. We would like to show that a role still exists for cycler + therapy (cycler therapy with a wet day or with only one manual exchange) in these patients, both for obtaining target Kt/V and for lifestyle. Using the PD Adequest computer program (Baxter Healthcare Corporation, Deerfield, IL, U.S.A.), we compared a night-exchange device [3 exchanges during the day and 2 exchanges during the night (3 + 2)] to various regimes of cycler + therapy. In all cases, the night-exchange volume exceeded the day-exchange volume by 500 mL. Using cycler + therapy in anuric patients with a low-transport membrane, with 6-7 exchanges over 9 hours, Kt/V can be increased by 10%-25%. A role therefore still exists for cycler + therapy in anuric patients with a low-transport membrane for lifestyle or to achieve a better Kt/V. Unfortunately, we saw no significant improvement in creatinine clearance.
Related Concept Videos
Drug Elimination by Renal Route: Tubular Secretion
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Hepatic Drug Clearance: Role of Transporters
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

